LBTD — Lotus Bio-Technology Development Balance Sheet
0.000.00%
IndustrialsHighly SpeculativeMicro Cap
Annual balance sheet for Lotus Bio-Technology Development, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2013 March 31st | R2014 March 31st | 2015 March 31st | R2016 March 31st | 2017 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K/A |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.004 | 0 | 0.002 | 0.002 | 0 |
Total Current Assets | 0.004 | 0 | 0.002 | 0.002 | 0 |
Net Property, Plant And Equipment | — | — | — | 0 | — |
Total Assets | 0.004 | 0 | 0.002 | 0.002 | 0 |
Accounts Payable | |||||
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.013 | 0.026 | 0.047 | 0.047 | 0.081 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.013 | 0.026 | 0.047 | 0.047 | 0.081 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -0.009 | -0.026 | -0.045 | -0.045 | -0.081 |
Total Liabilities & Shareholders' Equity | 0.004 | 0 | 0.002 | 0.002 | 0 |
Total Common Shares Outstanding |